News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
AFEYAN NOUBAR
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 10/06/2023 |
4
| AFEYAN NOUBAR (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Sold 1,030 shares
@ $100.0176, valued at
$103k
Sold 1,800 shares
@ $100.9389, valued at
$181.7k
Sold 2,700 shares
@ $102.0317, valued at
$275.5k
Sold 5,604 shares
@ $103.2201, valued at
$578.4k
Sold 3,866 shares
@ $104.0368, valued at
$402.2k
|
|
| 10/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 09/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/25/2023 |
4
| AFEYAN NOUBAR (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Sold 311 shares
@ $112.6116, valued at
$35k
Sold 854 shares
@ $113.8344, valued at
$97.2k
Sold 3,657 shares
@ $115.1558, valued at
$421.1k
Sold 9,878 shares
@ $115.8446, valued at
$1.1M
Sold 300 shares
@ $116.46, valued at
$34.9k
|
|
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/18/2023 |
4
| AFEYAN NOUBAR (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Sold 1,600 shares
@ $95.7025, valued at
$153.1k
Sold 2,900 shares
@ $96.4387, valued at
$279.7k
Sold 1,200 shares
@ $98.0658, valued at
$117.7k
Sold 4,000 shares
@ $98.8222, valued at
$395.3k
Sold 300 shares
@ $99.5, valued at
$29.9k
|
|
| 08/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/15/2023 |
4
| Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sigilon Therapeutics, Inc.|
Txns:
| Unknown transaction of 683,760 shares
@ $14.92, valued at
$10.2M
Unknown transaction of 113,960 shares
@ $14.92, valued at
$1.7M
|
|
| 08/14/2023 |
13F-NT
| Form 13F-NT - Quarterly report filed by institutional managers, Notice: |
| 08/04/2023 |
4
| AFEYAN NOUBAR (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Sold 9,725 shares
@ $110.5876, valued at
$1.1M
Sold 4,175 shares
@ $111.4608, valued at
$465.3k
Sold 900 shares
@ $112.5867, valued at
$101.3k
Sold 200 shares
@ $113.675, valued at
$22.7k
|
|
| 08/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2023 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Bought 1,082,251 shares
@ $2.31, valued at
$2.5M
Bought 1,082,251 shares
@ $2.31, valued at
$2.5M
Bought 3,246,753 shares
@ $2.31, valued at
$7.5M
|
|
| 07/12/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/07/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
4
| AFEYAN NOUBAR (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Sold 1,700 shares
@ $119.8371, valued at
$203.7k
Sold 3,131 shares
@ $120.7674, valued at
$378.1k
Sold 8,073 shares
@ $121.8721, valued at
$983.9k
Sold 2,096 shares
@ $122.825, valued at
$257.4k
|
|
| 06/28/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
4
| AFEYAN NOUBAR (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Sold 5,471 shares
@ $125.4302, valued at
$686.2k
Sold 5,997 shares
@ $126.1728, valued at
$756.7k
Sold 3,002 shares
@ $127.1895, valued at
$381.8k
Sold 530 shares
@ $128.1464, valued at
$67.9k
|
|
| 06/09/2023 |
4
| AFEYAN NOUBAR (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Sold 12,298 shares
@ $125.756, valued at
$1.5M
Sold 2,702 shares
@ $126.5929, valued at
$342.1k
|
|
| 06/09/2023 |
4
| AFEYAN NOUBAR (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.|
Txns:
| Granted 18,118 options to buy
@ $8.39, valued at
$152k
|
|
| 06/08/2023 |
4
| Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Sold 181,461 shares
@ $6.3061, valued at
$1.1M
Sold 22,297 shares
@ $6.3061, valued at
$140.6k
Sold 177,240 shares
@ $6.2397, valued at
$1.1M
Sold 22,760 shares
@ $6.2397, valued at
$142k
|
|
| 06/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
4
| AFEYAN NOUBAR (Director) has filed a Form 4 on Moderna, Inc.|
Txns:
| Sold 2,949 shares
@ $125.6921, valued at
$370.7k
Sold 3,373 shares
@ $126.7241, valued at
$427.4k
Sold 5,637 shares
@ $127.8391, valued at
$720.6k
Sold 2,441 shares
@ $128.5456, valued at
$313.8k
Sold 600 shares
@ $129.6783, valued at
$77.8k
|
|
| 05/31/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/26/2023 |
4
| Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sana Biotechnology, Inc.|
Txns:
| Sold 308,290 shares
@ $6.5652, valued at
$2M
Sold 39,580 shares
@ $6.5652, valued at
$259.9k
Sold 102,245 shares
@ $6.3522, valued at
$649.5k
Sold 13,127 shares
@ $6.3522, valued at
$83.4k
Sold 72,670 shares
@ $6.2265, valued at
$452.5k
Sold 9,330 shares
@ $6.2265, valued at
$58.1k
|
|
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|